This supplement will evaluate the utility of hemodynamic parameter maps extracted from resting state fMRI data, as early markers of cerebrovascular dysfunction in Alzheimer?s Disease (AD). We have developed a method to derive maps of cerebrovascular function and dysfunction from resting state data, including through retrospective analysis of existing public datasets. These metrics are sensitive to both macrovascular and microvascular changes. In healthy tissue, vasodilation modulates cerebral perfusion in response to changing demands for oxygen and nutrients; this ability is reduced or absent in many forms of cerebrovascular pathology. Cerebrovascular reactivity (CVR), is a measure of brain blood vessels? capacity for vasodilation, which offer useful information on the health of local vasculature. Traditional analysis methods of hypercarbic CVR data underestimate CVR magnitude in regions where the response is delayed with respect to the gas administration schedule, and give no information at all about blood flow delay, a crucial feature of vascular dysfunction. We have validated a method to quantitatively map delays in blood flow arrival, and other hemodynamic parameters, even in the absence of external manipulations, allowing us to differentiate the circulatory and metabolic components of cerebrovascular compromise from resting state data alone. We have already demonstrated the utility of this approach in primarily circulatory disorders, such as stroke and moyamoya disease; this supplement seeks to establish the utility of this approach to probe early circulatory dysfunction in AD. Specific patterns of local alteration in circulation may precede (or even lead to) neuronal degeneration, and may serve as an effective biomarker for following disease progression. This supplement would be used to test this hypothesis in two ways. First, we will add a focused cohort of patients with mild cognitive impairment or probable mild Alzheimer?s Disease (16 subjects) to our active protocol studying subjects at risk for stroke. We will perform an abbreviated version of our extensive circulatory evaluation protocol to determine circulatory markers of early AD relative to our comparison group. Second, we will perform a broad retrospective analysis on the resting state fMRI data in the ADNI (Alzheimer?s Disease Neuroimaging Initiative) database to measure circulatory parameters in a very large group that includes a range of diagnoses, and longitudinal data from a subset of subjects, to determine how regional bloodflow changes with disease progress. Finally, we will design and test machine learning classifiers to evaluate the ability of these circulatory markers to detect early AD/PRAD. These complementary efforts will test the hypothesis that specific, regional patterns of circulatory alteration progress with Alzheimer?s Disease, and may in fact precede other symptoms, allowing early, objective and quantitative detection of AD, and tracking of disease progression. Furthermore, this will serve as excellent preliminary data for designing more comprehensive efforts to develop this technique as an effective clinical tool.

Public Health Relevance

Cerebral hemodynamics plays an important role in Alzheimer?s Disease and related dementias. However, existing assessment methods are not well suited to fully quantifying blood flow in pathology in the presence of delayed blood flow; delayed blood arrival is often misinterpreted as blood volume or flow decreases. In this supplement, we will extend our novel fMRI processing methods for extracting high quality hemodynamic parameters, including blood flow delay, from resting state fMRI data, currently being used to assess stroke risk, to examine the circulatory changes seen in early Alzheimer?s disease, in order to evaluate these parameters as an early biomarker to predict disease progression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS097512-03S1
Application #
9717641
Study Section
Program Officer
Koenig, James I
Project Start
2018-09-11
Project End
2021-05-31
Budget Start
2018-09-11
Budget End
2019-05-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Mclean Hospital
Department
Type
DUNS #
046514535
City
Belmont
State
MA
Country
United States
Zip Code
Janes, A C; Gilman, J M; Frederick, B B et al. (2018) Salience network coupling is linked to both tobacco smoking and symptoms of attention deficit hyperactivity disorder (ADHD). Drug Alcohol Depend 182:93-97
Tong, Yunjie; Yao, Jinxia Fiona; Chen, J Jean et al. (2018) The resting-state fMRI arterial signal predicts differential blood transit time through the brain. J Cereb Blood Flow Metab :271678X17753329
Yang, Ho-Ching Shawn; Liang, Zhenhu; Yao, Jinxia Fiona et al. (2018) Vascular effects of caffeine found in BOLD fMRI. J Neurosci Res :
Li, Yingwei; Zhang, Haibing; Yu, Meiling et al. (2018) Systemic low-frequency oscillations observed in the periphery of healthy human subjects. J Biomed Opt 23:1-11
Cogswell, Petrice M; Davis, Taylor L; Strother, Megan K et al. (2017) Impact of vessel wall lesions and vascular stenoses on cerebrovascular reactivity in patients with intracranial stenotic disease. J Magn Reson Imaging 46:1167-1176